Related references
Note: Only part of the references are listed.Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience
Zafirah Zahir et al.
RENAL FAILURE (2021)
The clinical and immunological features of the post-extracorporeal shock wave lithotripsy anti-glomerular basement membrane disease
Beining Wang et al.
RENAL FAILURE (2021)
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2021)
Relapse of treated anti-GBM disease following hair dye use
James Povey et al.
BMJ CASE REPORTS (2021)
Rituximab use in adult glomerulopathies and its rationale
Joana Eugenio Santos et al.
JORNAL BRASILEIRO DE NEFROLOGIA (2020)
Rituximab in treatment of anti-GBM antibody glomerulonephritis A case report and literature review
Mayu Uematsu-Uchida et al.
MEDICINE (2019)
Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease
M. Heitz et al.
BMC NEPHROLOGY (2018)
Rituximab in anti-GBM disease: A retrospective study of 8 patients
Maxime Touzot et al.
JOURNAL OF AUTOIMMUNITY (2015)
Diagnosis and classification of Goodpasture's disease (anti-GBM)
Thomas Hellmark et al.
JOURNAL OF AUTOIMMUNITY (2014)
Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
Ghassan Bandak et al.
CLINICAL KIDNEY JOURNAL (2014)
Anti-glomerular basement membrane antibody disease treated with rituximab: A case-based review
Uzma A. Syeda et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Rituximab in anti-glomerular basement membrane disease
Y. Shah et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2012)
Advances in human antiglomerular basement membrane disease
Zhao Cui et al.
NATURE REVIEWS NEPHROLOGY (2011)
The association of HLA-DQB1,-DQA1 and-DPB1 alleles with anti- glomerular basement membrane (GBM) disease in Chinese patients
Huan Luo et al.
BMC NEPHROLOGY (2011)
The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease
Wataru Kitagawa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
K Arzoo et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression
JB Levy et al.
ANNALS OF INTERNAL MEDICINE (2001)